LAMP
The molecular test is used to differentiate bacterial infections, viral infections, and noninfectious disease and to assess the risk that patients will develop severe illness.
Inflammatix Raises $57M in Series E Financing
The company said that it will use the money to support regulatory filings and commercialization of its 30-minute TriVerity Acute Infection and Sepsis Test.
The Paris-based startup plans to use €1.5 million in pre-seed funding to support R&D on a test kit and deliver preclinical data by early 2025.
Startup En Carta Gets €1.5M for Development of Lyme Disease Test
The Paris-based firm will use the money to support the development of its Lyme disease test kit that will be used for early detection following a tick bite.
The firm has updated its low-cost Hub instrument and pivoted its testing menu toward multiplex point-of-care panels.
Nov 28, 2023
Oct 11, 2023
Sep 14, 2023
Apr 27, 2023
Apr 21, 2023
Feb 1, 2023